4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000099
Chief Commercial Officer sold 1,618 shares at $28.36 ($45,886)
- Chief Commercial Officer acquired 5,449 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Milanova Tsveta · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,449 | 5,449 | D | ||
| 2023-06-30 | Sale : show line 2 in the form 10b5-1 | −1,618 | $28.36 | $45,886 | 3,831 | D |
| Open-market sales · 1,618 sh · avg $28.36 · $45,886 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −5,449 | 5,448 | D |
Loading xslF345X04/wk-form4_1688155347.xml…